Ebola virus disease (EVD) often leads to a severe and fatal outcomes in humans with early supportive care increasing the chances of survival. Profiling the human plasma lipidome provides insight into critical illness as well as diseased states as lipids have essential roles as membrane structural components, signaling molecules, and energy sources. Here we show that the plasma lipidomes of EVD survivors and fatalities from Sierra Leone, infected during the 2014-2016 Ebola virus outbreak, was profoundly altered. Focusing on how lipids are associated in human plasma, while factoring in the state of critical illness, we found that lipidome changes were related to EVD outcome, and could identify states of critical illness, disease, and recovery. Specific changes in the lipidome suggested contributions from extracellular vesicles, viremia, liver dysfunction, apoptosis, autophagy and general critical illness, and identified possible targets for therapies enhancing EVD survival.
Revised: August 11, 2020 |
Published: February 26, 2019
Citation
Kyle J.E., K.E. Burnum-Johnson, J.P. Wendler, A.J. Eisfeld, P.J. Halfmann, T. Watanabe, and F. Sahr, et al. 2019.Plasma lipidome reveals critical illness and recovery from human Ebola virus disease.Proceedings of the National Academy of Sciences (PNAS) 116, no. 9:3919-3928.PNNL-SA-136689.doi:10.1073/pnas.1815356116